Eyenovia, Inc. (EYEN)
Eyenovia, Inc., a clinical stage ophthalmic company, engages in developing therapeutics based on its proprietary microdose array print platform technology. The company focuses on developing clinical microdosing of formulations of ophthalmic pharmaceutical agents using its Optejet branded targeted ocular delivery system. It focuses on the development of therapeutic indications for patients with progressive myopia and age-related near vision impairment or presbyopia indications; and microdose fixed combination ophthalmic pharmaceutical for mydriasis to address the eye exams with pupil dilation. The company's product candidates include MicroLine, which is in Phase III clinical development program with indications for the improvement in near vision in people with presbyopia; MicroPine, which is in Phase III clinical development program with indications for pediatric myopia progression (near-sightedness); and MydCombi, which is in Phase III clinical development program with indications for pharmaceutical mydriasis. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; and a license agreement with Arctic Vision (Hong Kong) Limited to develop and commercialize MicroPine and MicroLine in China and South Korea. The company was formerly known as PGP Holdings V, Inc. and changed its name to Eyenovia, Inc. in May 2014. Eyenovia, Inc. was incorporated in 2014 and is headquartered in New York, New York.
$40.63M
Mr. Michael M. Rowe
43.00
New York, NY
Jan 25, 2018
-0.68
$-0.78
0.48
0.83
-369,519.72%
-1.97
-0.12
35.13
9,587.89
0.52
-123.94%
-349.62%
Similar stocks (15)
ImmunityBio, Inc.
IBRX
Ardelyx, Inc.
ARDX
Ocular Therapeutix, Inc.
OCUL
Lexicon Pharmaceuticals, Inc.
LXRX
Anavex Life Sciences Corp.
AVXL
Inozyme Pharma, Inc.
INZY
Greenwich LifeSciences, Inc.
GLSI
Tenaya Therapeutics, Inc.
TNYA
Seres Therapeutics, Inc.
MCRB
Kodiak Sciences Inc.
KOD
Cidara Therapeutics, Inc.
CDTX
Fortress Biotech, Inc.
FBIO
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Cognition Therapeutics, Inc.
CGTX
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (8)
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (15)
ImmunityBio, Inc.
IBRX
Ardelyx, Inc.
ARDX
Ocular Therapeutix, Inc.
OCUL
Lexicon Pharmaceuticals, Inc.
LXRX
Anavex Life Sciences Corp.
AVXL
Inozyme Pharma, Inc.
INZY
Greenwich LifeSciences, Inc.
GLSI
Tenaya Therapeutics, Inc.
TNYA
Seres Therapeutics, Inc.
MCRB
Kodiak Sciences Inc.
KOD
Cidara Therapeutics, Inc.
CDTX
Fortress Biotech, Inc.
FBIO
Reviva Pharmaceuticals Holdings, Inc.
RVPH
Cognition Therapeutics, Inc.
CGTX
TransCode Therapeutics, Inc.
RNAZ
ETF Exposure (8)
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%